Inhibition of ATR Leads to Increased Sensitivity to Hypoxia/Reoxygenation

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-04-1520PMID 15374968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fragile sites: breaking up over a slowdown.

  2003cited by this paper
• Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance.

  2003cited by this paper
• Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation

  2003cited by this paper
• Clinical Impact of ATR Checkpoint Signalling Failure in Humans

  2003cited by this paper
• Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes

  2003influential reference
• A central role for DNA replication forks in checkpoint activation and response.

  2003cited by this paper
• A splicing mutation affecting expression of ataxia–telangiectasia and Rad3–related protein (ATR) results in Seckel syndrome

  2003cited by this paper
• DNA replication-dependent nuclear dynamics of the Mre11 complex.

  2003cited by this paper
• Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest.

  2003influential reference
• ATR/ATM Targets Are Phosphorylated by ATR in Response to Hypoxia and ATM in Response to Reoxygenation*

  2003cited by this paper
• Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.

  2003cited by this paper
• Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent Phosphorylation of Chk1 on Ser-317 in Response to Ionizing Radiation*

  2003cited by this paper
• Genomic instability and endoreduplication triggered by RAD17 deletion.

  2003cited by this paper
• Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein.

  2003cited by this paper
• Hypoxia Links ATR and p53 through Replication Arrest

  2002influential reference
• UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.

  2002cited by this paper
• Tumor Microenvironment and the Response to Anticancer Therapy

  2002cited by this paper
• The DNA replication checkpoint response stabilizes stalled replication forks

  2001cited by this paper
• Hydroxyurea Induces Site‐specific DNA Damage via Formation of Hydrogen Peroxide and Nitric Oxide

  2001cited by this paper
• Cell cycle checkpoint signaling through the ATM and ATR kinases.

  2001cited by this paper
• ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses

  2001cited by this paper
• Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development

  2001cited by this paper
• The many substrates and functions of ATM

  2000cited by this paper
• Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

  2000cited by this paper
• ATR disruption leads to chromosomal fragmentation and early embryonic lethality.

  2000cited by this paper
• Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice.

  2000cited by this paper
• Hypoxic microenvironment within an embryo induces apoptosis and is essential for proper morphological development.

  1999cited by this paper
• Hypoxic cervical cancers with low apoptotic index are highly aggressive.

  1999cited by this paper
• A role for ATR in the DNA damage-induced phosphorylation of p53.

  1999cited by this paper
• The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

  1998cited by this paper
• Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis

  1998cited by this paper
• Recombinant ATM protein complements the cellular A-T phenotype

  1997cited by this paper
• Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

  1996cited by this paper
• cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein.

  1996cited by this paper
• Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

  1996cited by this paper
• Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

  1993cited by this paper
• Reversible shutdown of replicon initiation by transient hypoxia in Ehrlich ascites cells. Dependence of initiation on short-lived protein.

  1992cited by this paper
• Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay.

  1990cited by this paper
• Heterogeneity in Radiation-Induced DNA Damage and Repair in Tumor and Normal Cells Measured Using the “Comet” Assay

  1990cited by this paper
• Oxygen dependent regulation of mammalian ribonucleotide reductase in vivo and possible significance for replicon initiation.

  1989cited by this paper
• Hydroxyurea.

  1975cited by this paper

• Exploring the Efficacy of AZD6738 in Corneal Neovascularization: Autophagy Enhancement and Angiogenesis Inhibition

  2025cites this paper
• Tumour hypoxia in driving genomic instability and tumour evolution

  2025cites this paper
• Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy.

  2023cites this paper
• Novel Cellular Functions of ATR for Therapeutic Targeting: Embryogenesis to Tumorigenesis

  2023cites this paper
• The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment.

  2022cites this paper
• Overcoming the Impact of Hypoxia in Driving Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Activation of p53 in anoxic freshwater crayfish, Faxonius virilis.

  2022cites this paper
• Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter

  2021cites this paper
• The Application of ATR Kinase Inhibitor AZD6738 in Combination with Radiotherapy for the Treatment of Melanoma

  2020cites this paper
• Inside the hypoxic tumour: reprogramming of the DDR and radioresistance

  2020cites this paper
• Inside the hypoxic tumour: reprogramming of the DDR and radioresistance

  2020cites this paper
• Targeting DNA repair pathways: mechanisms and potential applications in cancer therapy

  2020cites this paper
• Phosphorylation of seryl-tRNA synthetase by ATM/ATR is essential for hypoxia-induced angiogenesis

  2020cites this paper
• 2017–2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer

  2019cites this paper
• Impact of hypoxia on DNA repair and genome integrity.

  2019cites this paper
• ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation

  2018cites this paper
• Targeting ATR for Cancer Therapy: Profile and Expectations for ATR Inhibitors

  2018cites this paper
• Challenges to DNA replication in hypoxic conditions

  2018cites this paper
• Targeting ATR for Cancer Therapy: ATR-Targeted Drug Candidates

  2018cites this paper
• Heterogeneous impact of hypoxia on cellular radiation sensitivity of three squamous cell carcinoma lines

  2018cites this paper
• Liposomal formulation of hypoxia activated prodrug for the treatment of ovarian cancer

  2018cites this paper
• ATR/CHK1 inhibitors and cancer therapy.

  2017cites this paper
• Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids

  2017cites this paper
• LC–MS/MS assay for the simultaneous quantitation of the ATM inhibitor AZ31 and the ATR inhibitor AZD6738 in mouse plasma

  2017cites this paper
• Targeting ATR in cancer medicine.

  2017cites this paper
• Cell-line dependent effects of hypoxia prior to irradiation in squamous cell carcinoma lines

  2017cites this paper
• Genomic analysis of snub-nosed monkeys (Rhinopithecus) identifies genes and processes related to high-altitude adaptation

  2016cites this paper
• Measuring DNA Replication in Hypoxic Conditions.

  2016cites this paper
• Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy.

  2016cites this paper
• Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei

  2016cites this paper
• Targeting lung cancer through inhibition of checkpoint kinases

  2015cites this paper
• The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo

  2015cites this paper
• Targeting cyclic hypoxia to prevent malignant progression and therapeutic resistance of cancers.

  2015cites this paper
• Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.

  2015cites this paper
• Molecular Pathways: Targeting ATR in Cancer Therapy

  2015cites this paper
• Contributions à l'étude de la réponse moléculaire à l'hypoxie : Modélisation mathématique et expérimentations sur cellules FUCCI

  2015cites this paper
• Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy

  2015cites this paper
• Visualizing cell-cycle kinetics after hypoxia/reoxygenation in HeLa cells expressing fluorescent ubiquitination-based cell cycle indicator (Fucci).

  2015cites this paper
• The meaning, measurement and modification of hypoxia in the laboratory and the clinic.

  2014cites this paper
• ATM activation in hypoxia - causes and consequences

  2014cites this paper
• Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970

  2014cites this paper
• Hypoxia and the DNA Damage Response

  2014cites this paper
• Upregulation of the ATR‐CHEK1 pathway in oral squamous cell carcinomas

  2014cites this paper
• γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition

  2014cites this paper
• Targeting ATR in DNA damage response and cancer therapeutics.

  2014cites this paper
• Hypoxic Stress Facilitates Acute Activation and Chronic Downregulation of Fanconi Anemia Proteins

  2014cites this paper
• CH-01 is a Hypoxia-Activated Prodrug That Sensitizes Cells to Hypoxia/Reoxygenation Through Inhibition of Chk1 and Aurora A

  2013cites this paper
• ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression

  2013cites this paper
• Chimeric NKG2D-Modified T Cells NKG2D Ligands and Can Be Targeted by Mouse Tumor Vasculature Expresses

  2013cites this paper
• Inhibition of the non homologous end joining process in the context of hypoxic tumor cells

  2013cites this paper
• Genetic Instability Induced by Hypoxic Stress

  2013cites this paper
• Impact of Wee1 inhibition on the hypoxia-induced DNA damage response

  2013cites this paper
• WEE1-inhibition and hypoxia : The impact of hypoxia and reoxygenation on the S-phase effects of the WEE1-inhibitor MK-1775

  2013cites this paper
• Hypoxic Conditions ATM Activation and Signaling under

  2013cites this paper
• HIF1‐regulated ATRIP expression is required for hypoxia induced ATR activation

  2013cites this paper
• The Efficacy of CHK1 Inhibitors Is Not Altered by Hypoxia, but Is Enhanced after Reoxygenation

  2013influential citation
• New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress.

  2012cites this paper
• Mouse Tumor Vasculature Expresses NKG2D Ligands and Can Be Targeted by Chimeric NKG2D-Modified T Cells

  2012cites this paper
• Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia

  2012cites this paper
• Targeting radiation-resistant hypoxic tumour cells through ATR inhibition

  2012cites this paper
• Selective targeting of cancer cells through inhibition of Checkpoint kinase 1

  2012influential citation
• Hypoxia Activates Tumor Suppressor p53 by Inducing ATR-Chk1 Kinase Cascade-mediated Phosphorylation and Consequent 14-3-3γ Inactivation of MDMX Protein*

  2012cites this paper
• Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability

  2012influential citation
• Targeting hypoxia in cancer therapy

  2011cites this paper
• A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia

  2011cites this paper
• Hypoxic activation of ATR and the suppression of the initiation of DNA replication through cdc6 degradation

  2011influential citation
• Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication

  2011cites this paper
• Hypoxia and Modulation of Cellular Radiation Response

  2011cites this paper
• Convergent Transcription through a Long CAG Tract Destabilizes Repeats and Induces Apoptosis

  2010cites this paper
• Molecular Pathways Targeting Hypoxic Cells through the DNA Damage Response

  2010cites this paper
• Chapter 10. Hypoxia and the DNA Damage Response

  2010cites this paper
• Targeting Hypoxic Cells through the DNA Damage Response

  2010cites this paper
• Exposure to acute hypoxia induces a transient DNA damage response which includes Chk1 and TLK1

  2010cites this paper
• Chk1 suppressed cell death

  2010cites this paper
• Functional Significance for a Heterogenous Ribonucleoprotein A18 Signature RNA Motif in the 3′-Untranslated Region of Ataxia Telangiectasia Mutated and Rad3-related (ATR) Transcript*

  2010cites this paper
• Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability.

  2010cites this paper
• Targeting the DNA damage response for cancer therapy.

  2009cites this paper
• ATR and Chk1 Suppress a Caspase-3–Dependent Apoptotic Response Following DNA Replication Stress

  2009cites this paper
• Histone H2AX is integral to hypoxia-driven neovascularization

  2009cites this paper
• Elucidating the role of Cdc25A in hypoxia-mediated cell cycle arrest

  2009influential citation
• Tumor hypoxia as a modifier of DNA strand break and cross-link repair.

  2009cites this paper
• Hypoxic Conditions Atm Activation and Signaling Under

  2008cites this paper
• Targeting ATM/ATR in the DNA Damage Checkpoint

  2008cites this paper
• DNA repair pathways as targets for cancer therapy

  2008cites this paper
• Histone H2AX-dependent GABAA receptor regulation of stem cell proliferation

  2008cites this paper
• Amplifying tumour-specific replication lesions by DNA repair inhibitors - a new era in targeted cancer therapy.

  2008cites this paper
• ATM Activation and Signaling under Hypoxic Conditions

  2008cites this paper
• Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro.

  2007cites this paper
• Overview of the DNA Damage Checkpoint

  2007cites this paper
• Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies.

  2007cites this paper
• BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage

  2007cites this paper
• Regulation of DNA repair in hypoxic cancer cells

  2007cites this paper
• Hypoxia-induced genetic instability—a calculated mechanism underlying tumor progression

  2007cites this paper
• Oxygen sensing and the DNA-damage response.

  2007cites this paper
• Gene regulation under low oxygen: holding your breath for transcription.

  2007cites this paper
• The roles of Chk 1 and Chk 2 in hypoxia and reoxygenation.

  2006cites this paper
• SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells.

  2006cites this paper
• The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression.

  2006cites this paper
• The DNA damage response pathway in oral squamous cell carcinoma

  2006cites this paper
• HIV-1 Vpr-Induced Apoptosis Is Cell Cycle Dependent and Requires Bax but Not ANT

  2006cites this paper